Arialys Therapeutics
Clinical trials sponsored by Arialys Therapeutics, explained in plain language.
-
Healthy volunteers help test safety of new brain drug
Knowledge-focused CompletedThis early-stage study tested a single dose of ART5803, a potential treatment for autoimmune encephalitis (brain inflammation caused by the body's own immune system), in 7 healthy adults. The goal was to check the drug's safety and how it interacts with IVIG, a common immune ther…
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC
-
First step: new drug for brain inflammation tested in healthy people
Knowledge-focused CompletedThis early-stage study tested the safety of a new drug called ART5803 in 64 healthy adults. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body. The goal was not to treat disease, but to gather ess…
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC